Terns Pharmaceuticals, Inc.
Status: Publicly traded
Direct answer
Terns Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker TERN.
Terns Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to advancing novel small-molecule treatments. Its primary focus lies in developing both standalone agents and combination therapies to address non-alcoholic steatohepatitis (NASH) and obesity. The company's pipeline includes several key drug candidates: TERN-101, a farnesoid X receptor agonist distinguished...
Can you invest in Terns Pharmaceuticals, Inc.?
Yes. Terns Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker TERN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Terns Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.